Most Tamoxifen side effects are mild, dose-related and settle as treatment continues. The reactions that matter clinically are rare but need to be recognised quickly.
Key takeaways
- Common effects: hot flushes, vaginal discharge, thromboembolism, endometrial change.
- Avoid Tamoxifen in history of VTE or endometrial carcinoma without specialist review.
- Dose-related effects often resolve by stepping back one strength.
- Severe or persistent reactions warrant stopping and seeking review.
Frequency bands
| Frequency | Reactions | Action |
|---|---|---|
| Very common (>10%) | hot flushes, vaginal discharge | Usually self-limiting; supportive measures and reassurance. |
| Common (1–10%) | thromboembolism, endometrial change | Review dose and timing; consider dose reduction. |
| Uncommon (<1%) | hypersensitivity, marked laboratory changes | Stop and arrange clinical assessment. |
| Rare | serious organ-specific reactions | Stop immediately; urgent medical attention. |
Reducing the burden
Take Tamoxifen exactly as directed: 20 mg once daily for five to ten years. Splitting titration into smaller steps, dosing with food where the label allows, and hydrating well cover most tolerability problems seen in practice.
Tamoxifen at a glance
| Attribute | Detail |
|---|---|
| Drug class | selective oestrogen receptor modulator |
| Common brand | Nolvadex |
| Licensed use | breast cancer treatment and risk reduction |
| Available strengths | 10 mg, 20 mg |
| Dosage form | film-coated tablet |
| Typical onset | biological effect immediate; recurrence benefit accrues over years |
| Duration / dosing interval | 24-hour dosing |
| Storage | below 30 °C, protect from light |